|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of United Therapeutics (NASDAQ: UTHR) through any online brokerage.
The latest price target for United Therapeutics (NASDAQ: UTHR) was reported by Argus Research on July 14, 2021. The analyst firm set a price target for 205.00 expecting UTHR to rise to within 12 months (a possible 10.22% upside). 6 analyst firms have reported ratings in the last year.
The stock price for United Therapeutics (NASDAQ: UTHR) is $185.99 last updated Fri Dec 03 2021 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for United Therapeutics.
United Therapeutics’s $Q4 earnings are confirmed for after-market on February 23, 2022.
There is no upcoming split for United Therapeutics.
United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.